Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/205161
Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
We report a series of small molecule proteolysis-targeting chimeras (PROTACs) that target the protein kinase p38α for degradation. These PROTACs are based on a ligand of the VHL E3 ubiquitin ligase, which is linked to an ATP competitive inhibitor of p38α. We provide evidence that these compounds can induce the specific degradation of p38α, but not p38β and other related kinases, at nanomolar concentrations in several mammalian cell lines. We also show that the p38α-specific PROTACs are soluble in aqueous solutions and therefore suitable for their administration to mice. Systemic administration of the PROTACs induces p38α degradation only in the liver, probably due to the PROTAC becoming inactivated in that organ, but upon local administration the PROTACs induce p38α degradation in mammary tumors. Our compounds provide an alternative to traditional chemical inhibitors for targeting p38α signaling in cultured cells and in vivo.
Subject (English)
Citation
Citation
CUBILLOS ROJAS, Mónica, et al. Synthesis and Biological Activity of a VHL-Based PROTAC Specific for p38α. Cancers. 2023. Vol. 15, num. 3. ISSN 2072-6694. [consulted: 12 of June of 2026]. Available at: https://hdl.handle.net/2445/205161